International Workshop on HIV and Adolescence 2021, 6-8 October 2021, Lusaka, Zambia
We are pleased to introduce two new members of the Organizing Committee for the International Workshop on HIV & Adolescence.
Allison Agwu and Nadia Sam-Agudu both have extensive experience in the field of HIV & Adolescence and we are excited to collaborate with them on this year's distinguished program.
We are passionate about providing a platform for young people to share their voices and experiences in this workshop.
To better enable young people to attend, we are pleased to waive the registration fee for all delegates that are 25 years of age and below. Additionally, we offer a 50% discount on the registration fee for all delegates that are 30 years of age and below.
Abstract submission will open on 1 April. We will accept two types of abstracts:
• Research Abstracts: Present the latest results from your study or research and discuss your findings with an expert audience.
• “Lessons Learned” Abstracts: What worked and what did not work? Share your experiences and exchange ideas with a multidisciplinary audience.
To receive this discount, please apply here: https://virology.eventsair.com/international-workshop-on-hiv-adolescence-2021/youthapplication
Visit our website for more information about registration and discounts: https://academicmedicaleducation.com/hiv-adolescence-2021
From Obstetrician to Research Centre Director Improving Women’s lives: Dr Atinuke Olaleye EDCTP-TDR Clinical Research and Development Fellow (2015), EDCTP Career Development Fellow (2015)
Congratulations to Dr Atinuke Olaleye who recently completely her EDCTP-TDR Clinical Research and Development Fellowship and returned to her home organisation, Babock University, Nigeria to implement her re-integration plan. She was hosted by GlaxoSmithKline in Belgium.
On her return she was appointed as Director of the Centre for Advanced Medical Research and Biotechnology (CAMRAB) at Babcock University in Nigeria. She currently holds an EDCTP Career Development Fellowship (TMA2015CDF973) titled 'Determinants and prevalence of parasite resistance among pregnant women receiving Intermittent Preventive Treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) in a malaria endemic community'.
We are proud to see the continuous development of Dr Atinuke and look forward to the results of her ongoing going study.
https://www.who.int/tdr/capacity/strengthening/career_development/atinuke-olaleye/en/
REDSSA Open call for creative ideas to improve awareness of data science health research - deadline for submission: 30 April 2023.
Large volumes of health-related data are collected from various sources we use every day, including computers, smartphones, tablets, and wearable devices. Anonymised health data are also collected by medical insurance companies in the private health sector and official public health databases to design treatment and prevention strategies to address various public health issues and benefit communities. However, there is a lack of awareness among the public that this data is being collected and shared. When this data is collected from an individual it is very personal and sensitive, but once anonymised as part of large data sets, it cannot easily be linked back to the individual. How should we engage with communities, using simple non-technical language, to raise awareness that sensitive individual health and location information is being collected and shared as part of a large, anonymised data set? Research for Ethical Data Science in sub-Saharan Africa (REDSSA) is seeking ideas for strategies to help improve transparency, understanding and trust in large data-driven health research for the public good. Deadline for submission: 30 April 2023.
More information https://www.sun.ac.za/english/faculty/healthsciences/cmel/redssa/crowdsourcing
Gavi recruiting consultant positions for its next Vaccine Investment Strategy (VIS)
Gavi is currently recruiting three consultant positions to support Gavi’s next Vaccine Investment Strategy (VIS). The VIS is Gavi’s evidence-informed process that takes place every 5 years to evaluate the full value of new vaccines (or underused ones) in support of Gavi’s Board investment decisions. Selected vaccines would then be included into Gavi’s portfolio at the next strategic period (2026-2030). The consultant roles are one-year roles with possibility of extension. Candidates are sought with experience in public health, epidemiology, health economics, impact modelling or closely related field and with strong quantitative and qualitative analysis skills. In particular, the consultant positions are a great opportunity for researchers with an interest in policy analysis and investment case development to get exposure to how policy and investment decisions are made, including engagement with numerous stakeholders.
The following consultants are being recruited:
1 x Senior manager (L4)
2 x Data analyst (L2)